Galer Bradley S.
Insider CIK 1594565 · ZGNX EVP/Chief Medical Officer · RAPP Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RAPP Rapport Therapeutics, Inc. | A Award deriv | 2024-06-06 | 2024-06-10 | 123,818 | — | $0 | 123,818 | SEC↗ |
| ZGNX ZOGENIX, INC. | D To issuer deriv | 2022-03-07 | 2022-03-09 | 53,125 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | D To issuer deriv | 2022-03-07 | 2022-03-09 | 28,500 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | D To issuer deriv | 2022-03-07 | 2022-03-09 | 28,125 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | D To issuer deriv | 2022-03-07 | 2022-03-09 | 8,125 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | D To issuer deriv | 2022-03-07 | 2022-03-09 | 60,000 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | D To issuer deriv | 2022-03-07 | 2022-03-09 | 45,499 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | D To issuer deriv | 2022-03-07 | 2022-03-09 | 30,000 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | D To issuer deriv | 2022-03-07 | 2022-03-09 | 39,000 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | D To issuer deriv | 2022-03-07 | 2022-03-09 | 60,000 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | U Tender | 2022-03-07 | 2022-03-09 | 25,022 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2021-08-09 | 2021-08-11 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2021-03-26 | 2021-03-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2021-03-26 | 2021-03-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise deriv | 2021-03-15 | 2021-03-17 | 1,625 | — | $0 | 4,875 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise deriv | 2021-03-15 | 2021-03-17 | 1,562 | — | $0 | 1,562 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise deriv | 2021-03-15 | 2021-03-17 | 2,031 | — | $0 | 4,062 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise | 2021-03-15 | 2021-03-17 | 1,625 | — | $0 | 22,258 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise | 2021-03-15 | 2021-03-17 | 1,562 | — | $0 | 19,609 | SEC↗ |
| ZGNX ZOGENIX, INC. | F Tax w/h | 2021-03-15 | 2021-03-17 | 438 | $20.70 | $9.1K | 19,171 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise | 2021-03-15 | 2021-03-17 | 2,031 | — | $0 | 21,202 | SEC↗ |
| ZGNX ZOGENIX, INC. | F Tax w/h | 2021-03-15 | 2021-03-17 | 569 | $20.70 | $11.8K | 20,633 | SEC↗ |
| ZGNX ZOGENIX, INC. | F Tax w/h | 2021-03-15 | 2021-03-17 | 455 | $20.70 | $9.4K | 21,803 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise deriv | 2020-06-25 | 2020-06-29 | 10,000 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise | 2020-06-25 | 2020-06-29 | 10,000 | — | $0 | 20,015 | SEC↗ |
| ZGNX ZOGENIX, INC. | F Tax w/h | 2020-06-25 | 2020-06-29 | 2,813 | $28.12 | $79.1K | 17,202 | SEC↗ |
| ZGNX ZOGENIX, INC. | P Buy | 2020-03-18 | 2020-03-20 | 1,000 | $19.69 | $19.7K | 10,015 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise deriv | 2020-03-15 | 2020-03-17 | 1,563 | — | $0 | 3,124 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise deriv | 2020-03-15 | 2020-03-17 | 2,032 | — | $0 | 6,093 | SEC↗ |
| ZGNX ZOGENIX, INC. | F Tax w/h | 2020-03-15 | 2020-03-17 | 429 | $22.01 | $9.4K | 7,541 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise | 2020-03-15 | 2020-03-17 | 2,032 | — | $0 | 9,573 | SEC↗ |
| ZGNX ZOGENIX, INC. | F Tax w/h | 2020-03-15 | 2020-03-17 | 558 | $22.01 | $12.3K | 9,015 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise | 2020-03-15 | 2020-03-17 | 1,563 | — | $0 | 7,970 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2020-03-04 | 2020-03-06 | 6,500 | — | $0 | 6,500 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2020-03-04 | 2020-03-06 | 39,000 | — | $0 | 39,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2019-03-22 | 2019-03-26 | 63,750 | — | $0 | 63,750 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2019-03-22 | 2019-03-26 | 8,125 | — | $0 | 8,125 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise deriv | 2019-03-15 | 2019-03-19 | 1,563 | — | $0 | 4,687 | SEC↗ |
| ZGNX ZOGENIX, INC. | F Tax w/h | 2019-03-15 | 2019-03-19 | 429 | $51.88 | $22.3K | 5,783 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise | 2019-03-15 | 2019-03-19 | 1,563 | — | $0 | 6,212 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2018-03-15 | 2018-03-16 | 37,500 | — | $0 | 37,500 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2018-03-15 | 2018-03-16 | 6,250 | — | $0 | 6,250 | SEC↗ |
| ZGNX ZOGENIX, INC. | P Buy | 2017-12-13 | 2017-12-15 | 1,346 | $36.59 | $49.3K | 4,033 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2017-03-14 | 2017-03-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2017-03-14 | 2017-03-16 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2016-03-14 | 2016-03-16 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2015-10-05 | 2015-10-07 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2015-03-17 | 2015-03-17 | 225,000 | — | $0 | 225,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2014-06-02 | 2014-06-04 | 65,000 | — | $0 | 490,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2013-12-17 | 2013-12-18 | 425,000 | — | $0 | 425,000 | SEC↗ |